Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Chronic Myeloid Leukemia Treatments, and Multiple Myeloma Research and Treatments.
"Quadruple-hit" primary testicular diffuse large B-cell lymphoma with MYD88 L265P mutation, IGH::MYC, and IRF4- and BCL6-rearrangements.
Characterization of unusual iAMP21 B-lymphoblastic leukemia (iAMP21-ALL) from the Mayo Clinic and Children's Oncology Group.
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling
Apparent coexistence of <i>ETV6::RUNX1</i> and <i>KMT2A::MLLT3</i> fusions due to a nonproductive <i>KMT2A</i> rearrangement in B-ALL.
Molecular classification improves risk assessment in adult <i>BCR-ABL1–</i>negative B-ALL
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Histiocytoid Sweet syndrome may indicate leukemia cutis: A novel application of fluorescence in situ hybridization
Mutations and prognosis in primary myelofibrosis
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
CD25 expression status improves prognostic risk classification in AML independent of established biomarkers: ECOG phase 3 trial, E1900
Integrative Epigenomic Analysis Identifies Biomarkers and Therapeutic Targets in Adult B-Acute Lymphoblastic Leukemia
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia